Rare Neurological Disease Treatment Market, By Drug Type (Biologics and Small Molecules), By Mode of Administration (Injectables, Oral and Other Modes of Administration), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Many factors influence the overall growth of the global market for treatments for rare neurological illnesses. The primary driving factor behind the global market's rise has been the increasing research and development efforts aimed at finding remedies for these ailments. Over the past few years, rare neurological illnesses have increased in frequency worldwide. Most are misdiagnosed or remain unreported. The primary factor propelling the major players in the market is the lack of suitable therapy, which will help the market grow in the upcoming years of the forecast period. Focusing on expediting approvals for new and upcoming medications to treat these kinds of illnesses is another important factor in the market's expansion. Additionally, recent developments in the sciences of neurology and neurobiology have